LOSARTAN POTASSIUM
| Brand name | ARBLI |
|---|---|
| Active ingredient | LOSARTAN POTASSIUM |
| Strength | 10MG/ML |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2025 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12156869 | October 2041 | product |
| 12605365 | October 2041 | product |
| 11890273 | October 2041 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.